                         SEQUENCE LISTING

<110>  MESO SCALE TECHNOLOGIES, LLC.
 
<120>  METHODS, COMPOSITIONS, AND KITS FOR DETECTING

<130>  0076-0052WO1

<150>  US 63/175,946
<151>  2021-04-16

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide detection reagent

<400>  1
atcatgtctg ggttacuuuu uuuuuuactg gtaacccaga catgatcggt                  50


<210>  2
<211>  43
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide detection reagent

<400>  2
catgtctggg ttacuuuuua ctggtaaccc agacatgatc ggt                         43


<210>  3
<211>  43
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide detection reagent

<400>  3
tcatgtctgg gttauuuuua ctggtaaccc agacatgatc ggt                         43


<210>  4
<211>  48
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide detection reagent

<400>  4
tcatgtctgg gttauuuuuu uuuuactggt aacccagaca tgatcggt                    48


<210>  5
<211>  45
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide detection reagent

<400>  5
tcatgtctgg gttaugugug uactggtaac ccagacatga tcggt                       45


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protease target sequence


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is Abu

<400>  6

Tyr Tyr Xaa Asn Glu Pro Tyr Lys 
1               5               


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protease target site

<400>  7

Gly Asp Glu Val Asp Gly Val Lys 
1               5               


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protease target site

<400>  8

Gly Trp Glu His Asp Gly Val Lys 
1               5               


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protease target site

<400>  9

Gly Trp Glu His Asp Gly Val Gly Trp Glu His Asp Gly Val Lys 
1               5                   10                  15  


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protease target site

<400>  10

Gly Val Glu His Asp Gly Val Lys 
1               5               


<210>  11
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protease target site

<400>  11

Gly Val Glu His Asp Gly Val Gly Val Glu His Asp Gly Val Lys 
1               5                   10                  15  


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protease target site

<400>  12

Ile Glu Gly Arg Lys 
1               5   


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Protease target site

<400>  13

Ile Asp Gly Arg Lys 
1               5   


<210>  14
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Targeting agent complement sequence

<400>  14
actggtaacc cagacatgat cggt                                              24


<210>  15
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Targeting agent complement sequence

<400>  15
ctaatagctc ctgtgccctc gtat                                              24


<210>  16
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Targeting agent complement sequence

<400>  16
aatccgtcga ctagcctgag aatt                                              24


<210>  17
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Targeting agent complement sequence

<400>  17
cgtaccattg aatctggaga cctt                                              24


